PT - JOURNAL ARTICLE AU - Yu Ri Jung AU - Eun Ju Kim AU - Hyeong Jwa Choi AU - Jung-Jin Park AU - Hak-Su Kim AU - Yoon-Jin Lee AU - Myung-Jin Park AU - Minyoung Lee TI - Aspirin Targets SIRT1 and AMPK to Induce Senescence of Colorectal Carcinoma Cells AID - 10.1124/mol.115.098616 DP - 2015 Oct 01 TA - Molecular Pharmacology PG - 708--719 VI - 88 IP - 4 4099 - http://molpharm.aspetjournals.org/content/88/4/708.short 4100 - http://molpharm.aspetjournals.org/content/88/4/708.full SO - Mol Pharmacol2015 Oct 01; 88 AB - Cancer therapies attempt to destroy the entire tumor, but this tends to require toxic compounds and high doses of radiation. Recently, considerable attention has focused on therapy-induced senescence (TIS), which can be induced in cancer cells by low doses of therapeutic drugs or radiation and provides a barrier to tumor development. However, the molecular mechanisms governing TIS remain elusive. Special attention has been paid to the potential chemopreventive effect of aspirin against human colorectal cancer. In this study, we investigated the effects of aspirin on TIS of human colorectal carcinoma (CRC) cells and show that it occurs via sirtuin 1 (SIRT1) and AMP-activated protein kinase (AMPK), two key regulators of cellular metabolism. Aspirin increased the senescence of CRC cells, increased the protein levels of SIRT1, phospho-AMPK (T172), and phospho-acetyl CoA carboxylase (S79), and reduced the cellular level of ATP. Small-interfering RNA–mediated downregulation or pharmacological inhibition of SIRT1 or AMPK significantly attenuated the aspirin-induced cellular senescence in CRC cells. In contrast, treatment with a SIRT1 agonist or an AMP analog induced cellular senescence. Remarkably, SIRT1 knockdown abrogated the aspirin-induced activation of AMPK, and vice versa. During the progression of aspirin-induced cellular senescence in CRC cells, SIRT1 showed increased deacetylase activity at a relatively early time point but was characterized by decreased activity with increased cytoplasmic localization at a later time point. Collectively, these novel findings suggest that aspirin could provide anticancer effects by inducing senescence in human CRC cells through the reciprocal regulation of SIRT1-AMPK pathways.